FDA Approves New Therapy for Myelodysplastic Syndromes (MDS) That Can Be Taken at Home | FDA News
For Immediate Release: July 07, 2020 Today, the U.S. Food and Drug Administration approved Inqovi (decitabine and cedazuridine) tablets for treatment of adult patients with myelodysplastic syndromes (MDS) and chronic…